More about
Outcomes Vitiligo
News
March 22, 2023
2 min read
Save
Patients with nonsegmental vitiligo see significant repigmentation with povorcitinib
NEW ORLEANS — Povorcitinib was associated with substantial repigmentation in patients with extensive nonsegmental vitiligo, according to a study presented at the American Academy of Dermatology Annual Meeting.